Skip to main content
. 2022 Nov 16;15:2495–2506. doi: 10.2147/CCID.S374122

Figure 2.

Figure 2

Disruption of microtubule architecture in PC3 and CCD-1106 KERTr cells by tirbanibulin (ATNXUS-KX01-001 study): representative figures of tubulin disruption in (A) PC3 and (B) CCD-1106 KERTr cells treated with tirbanibulin (100 and 200 nM, respectively) or control DMSO for 2 hours. Cells were then fixed, permeabilized, and stained with an antibody to tubulin. DMSO=dimethyl sulfoxide.